Sally E. Blount's Insider Trades & SAST Disclosures
Sally E. Blount's most recent trade in Abbott Laboratories was a trade of 2,600 Common shares without par value done at an average price of $129.7 . Disclosure was reported to the exchange on April 30, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Sally E. Blount.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Abbott Laboratories | Blount E. Sally | Director | Sale of securities on an exchange or to another person at price $ 129.66 per share. | 30 Apr 2025 | 2,600 | 34,058 (0%) | 0% | 129.7 | 337,116 | Common shares without par value |
| Abbott Laboratories | Sally E. Blount | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2025 | 1,635 | 36,658 (0%) | 0% | 0 | Common shares without par value | |
| Abbott Laboratories | Sally E. Blount | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 1,866 | 35,023 (0%) | 0% | 0 | Common shares without par value | |
| Abbott Laboratories | Sally E. Blount | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 1,816 | 33,157 (0%) | 0% | 0 | Common shares without par value | |
| Abbott Laboratories | Sally E. Blount | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2022 | 1,602 | 31,341 (0%) | 0% | 0 | Common shares without par value | |
| Ulta Beauty Inc | Sally E. Blount | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 476 | 1,071 | - | - | Restricted Stock Units | |
| Abbott Laboratories | Sally E. Blount | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2021 | 1,499 | 29,739 (0%) | 0% | 0 | Common shares without par value | |
| Ulta Beauty Inc | Sally E. Blount | Director | Purchase of securities on an exchange or from another person at price $ 193.00 per share. | 26 Jun 2020 | 250 | 1,239 (0%) | 0% | 193 | 48,250 | Common Stock |
| Ulta Beauty Inc | Sally E. Blount | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2020 | 595 | 595 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges